Osaic Holdings
ORMP icon

Osaic Holdings’s Oramed Pharmaceuticals ORMP Stock Holding History

Osaic Holdings’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.3K Sell
4,217
-107
-2% -$426 ﹤0.01% 6155
2026
Q1 		$14.7K Buy
4,324
+7
+0.2% +$24 ﹤0.01% 6058
2025
Q4 		$12.3K Hold
4,317
– – ﹤0.01% 6207
2025
Q3 		$9.54K Hold
4,317
– – ﹤0.01% 6395
2025
Q2 		$9.71K Sell
4,317
-232
-5% -$512 ﹤0.01% 6168
2025
Q1 		$9.73K Sell
4,549
-1,400
-24% -$3.23K ﹤0.01% 5800
2024
Q4 		$14.4K Buy
5,949
+2,100
+55% +$4.99K ﹤0.01% 5560
2024
Q3 		$9.39K Hold
3,849
– – ﹤0.01% 5856
2024
Q2 		$9.89K Sell
3,849
-800
-17% -$1.9K ﹤0.01% 5799
2024
Q1 		$13.6K Sell
4,649
-3,730
-45% -$10.4K ﹤0.01% 5577
2023
Q4 		$19.4K Sell
8,379
-11,300
-57% -$24.1K ﹤0.01% 5512
2023
Q3 		$51.4K Buy
19,679
+3,440
+21% +$10.8K ﹤0.01% 4989
2023
Q2 		$58.1K Sell
16,239
-1,817
-10% -$5.83K ﹤0.01% 4841
2023
Q1 		$39.3K Sell
18,056
-4,403
-20% -$14K ﹤0.01% 5115
2022
Q4 		$270K Sell
22,459
-2,242
-9% -$17.4K ﹤0.01% 3597
2022
Q3 		$161K Buy
24,701
+5,498
+29% +$44.5K ﹤0.01% 3953
2022
Q2 		$88K Buy
19,203
+2,849
+17% +$15.2K ﹤0.01% 4526
2022
Q1 		$137K Sell
16,354
-9,913
-38% -$102K ﹤0.01% 4338
2021
Q4 		$375K Buy
26,267
+8,697
+49% +$182K ﹤0.01% 3348
2021
Q3 		$386K Buy
17,570
+9,982
+132% +$170K ﹤0.01% 3299
2021
Q2 		$101K Buy
7,588
+2,863
+61% +$32.7K ﹤0.01% 4475
2021
Q1 		$48K Buy
4,725
+3,725
+373% +$30.6K ﹤0.01% 4914
2020
Q4 		$4K Buy
+1,000
New +$3.25K ﹤0.01% 5867
2020
Q2 		– Sell
-1,000
Closed -$3K – 6268
2020
Q1 		$3K Buy
+1,000
New +$4.38K ﹤0.01% 5559

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings's ORMP Position: Q2 2026 in Review

Osaic Holdings reduced its Oramed Pharmaceuticals (ORMP) stake by 2.5% in Q2 2026, selling an estimated $426 and leaving 4,217 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6155.

Osaic Holdings first reported a position in ORMP in Q1 2020 and has held it in 24 quarters since. The position peaked at $386K in Q3 2021. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Osaic Holdings held 4,217 shares of Oramed Pharmaceuticals worth $20.3K as of Q2 2026.
  • Osaic Holdings sold 107 Oramed Pharmaceuticals shares in Q2 2026, an estimated $426.
  • Oramed Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6155 holding.
  • Osaic Holdings first reported a position in Oramed Pharmaceuticals in Q1 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Oramed Pharmaceuticals position peaked at $386K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.